by homology
Contact email: handman@wehi.edu.au
Publication title: A Leucine-Rich Repeat Motif of Leishmania Parasite Surface Antigen 2 Binds to Macrophages through the Complement Receptor 3
Publication 1st author(s): Kedzierski
Publication Identifier(s): 15067069
Host organism: -1
Interaction detection method(s): fluorescence activated cell sorting
Interaction type: physical association
Identification method participant A: identification by antibody
Identification method participant B: identification by antibody
ID(s) interactor A: P11215
ID(s) interactor B: E9AGG4
Taxid interactor A: Homo sapiens
Taxid interactor B: Leishmania infantum
Biological role(s) interactor A: unspecified role
Biological role(s) interactor B: unspecified role
Experimental role(s) interactor A: unspecified role
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 110 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 40, no: 3 |
NetGPI | no | yes: 0, no: 43 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 44 |
GO:0016020 | membrane | 2 | 26 |
GO:0042995 | cell projection | 2 | 44 |
GO:0043226 | organelle | 2 | 44 |
GO:0043227 | membrane-bounded organelle | 3 | 44 |
GO:0110165 | cellular anatomical entity | 1 | 44 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 44 |
GO:0005886 | plasma membrane | 3 | 6 |
Related structures:
AlphaFold database: Q4QGJ2
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0004672 | protein kinase activity | 3 | 3 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 3 |
GO:0016301 | kinase activity | 4 | 3 |
GO:0016740 | transferase activity | 2 | 3 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 3 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 3 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.469 |
CLV_NRD_NRD_1 | 285 | 287 | PF00675 | 0.479 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.729 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.632 |
CLV_PCSK_KEX2_1 | 165 | 167 | PF00082 | 0.465 |
CLV_PCSK_KEX2_1 | 285 | 287 | PF00082 | 0.478 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.729 |
CLV_PCSK_PC1ET2_1 | 132 | 134 | PF00082 | 0.624 |
CLV_PCSK_PC1ET2_1 | 165 | 167 | PF00082 | 0.455 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 165 | 169 | PF00082 | 0.508 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.615 |
CLV_PCSK_SKI1_1 | 232 | 236 | PF00082 | 0.571 |
CLV_PCSK_SKI1_1 | 325 | 329 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.720 |
DEG_SCF_FBW7_1 | 539 | 546 | PF00400 | 0.425 |
DEG_SCF_FBW7_2 | 576 | 581 | PF00400 | 0.498 |
DEG_SPOP_SBC_1 | 449 | 453 | PF00917 | 0.483 |
DEG_SPOP_SBC_1 | 464 | 468 | PF00917 | 0.608 |
DEG_SPOP_SBC_1 | 474 | 478 | PF00917 | 0.567 |
DEG_SPOP_SBC_1 | 489 | 493 | PF00917 | 0.612 |
DEG_SPOP_SBC_1 | 499 | 503 | PF00917 | 0.587 |
DEG_SPOP_SBC_1 | 514 | 518 | PF00917 | 0.423 |
DEG_SPOP_SBC_1 | 524 | 528 | PF00917 | 0.447 |
DEG_SPOP_SBC_1 | 543 | 547 | PF00917 | 0.435 |
DEG_SPOP_SBC_1 | 556 | 560 | PF00917 | 0.606 |
DOC_CKS1_1 | 540 | 545 | PF01111 | 0.527 |
DOC_CYCLIN_RxL_1 | 226 | 237 | PF00134 | 0.290 |
DOC_CYCLIN_RxL_1 | 3 | 13 | PF00134 | 0.594 |
DOC_CYCLIN_RxL_1 | 373 | 384 | PF00134 | 0.277 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 236 | 245 | PF00134 | 0.258 |
DOC_CYCLIN_yCln2_LP_2 | 196 | 199 | PF00134 | 0.263 |
DOC_CYCLIN_yCln2_LP_2 | 76 | 82 | PF00134 | 0.246 |
DOC_MAPK_gen_1 | 132 | 139 | PF00069 | 0.261 |
DOC_MAPK_gen_1 | 325 | 332 | PF00069 | 0.249 |
DOC_MAPK_MEF2A_6 | 420 | 427 | PF00069 | 0.445 |
DOC_PP1_RVXF_1 | 227 | 234 | PF00149 | 0.265 |
DOC_PP2B_LxvP_1 | 196 | 199 | PF13499 | 0.263 |
DOC_PP2B_LxvP_1 | 76 | 79 | PF13499 | 0.249 |
DOC_USP7_MATH_1 | 251 | 255 | PF00917 | 0.263 |
DOC_USP7_MATH_1 | 347 | 351 | PF00917 | 0.421 |
DOC_USP7_MATH_1 | 400 | 404 | PF00917 | 0.465 |
DOC_USP7_MATH_1 | 556 | 560 | PF00917 | 0.625 |
DOC_USP7_MATH_1 | 624 | 628 | PF00917 | 0.314 |
DOC_USP7_MATH_2 | 150 | 156 | PF00917 | 0.350 |
DOC_USP7_MATH_2 | 198 | 204 | PF00917 | 0.299 |
DOC_USP7_MATH_2 | 270 | 276 | PF00917 | 0.305 |
DOC_USP7_MATH_2 | 294 | 300 | PF00917 | 0.285 |
DOC_WW_Pin1_4 | 223 | 228 | PF00397 | 0.384 |
DOC_WW_Pin1_4 | 539 | 544 | PF00397 | 0.462 |
DOC_WW_Pin1_4 | 568 | 573 | PF00397 | 0.582 |
DOC_WW_Pin1_4 | 574 | 579 | PF00397 | 0.557 |
LIG_14-3-3_CanoR_1 | 133 | 138 | PF00244 | 0.302 |
LIG_14-3-3_CanoR_1 | 232 | 237 | PF00244 | 0.349 |
LIG_14-3-3_CanoR_1 | 278 | 283 | PF00244 | 0.340 |
LIG_14-3-3_CanoR_1 | 43 | 48 | PF00244 | 0.438 |
LIG_14-3-3_CanoR_1 | 85 | 95 | PF00244 | 0.300 |
LIG_Actin_WH2_2 | 155 | 170 | PF00022 | 0.299 |
LIG_Actin_WH2_2 | 200 | 218 | PF00022 | 0.265 |
LIG_Actin_WH2_2 | 272 | 287 | PF00022 | 0.284 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.705 |
LIG_deltaCOP1_diTrp_1 | 62 | 69 | PF00928 | 0.354 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.438 |
LIG_FHA_1 | 144 | 150 | PF00498 | 0.359 |
LIG_FHA_1 | 192 | 198 | PF00498 | 0.371 |
LIG_FHA_1 | 216 | 222 | PF00498 | 0.350 |
LIG_FHA_1 | 279 | 285 | PF00498 | 0.295 |
LIG_FHA_1 | 326 | 332 | PF00498 | 0.291 |
LIG_FHA_1 | 42 | 48 | PF00498 | 0.443 |
LIG_FHA_1 | 612 | 618 | PF00498 | 0.511 |
LIG_FHA_1 | 81 | 87 | PF00498 | 0.349 |
LIG_FHA_2 | 556 | 562 | PF00498 | 0.501 |
LIG_FHA_2 | 580 | 586 | PF00498 | 0.495 |
LIG_FHA_2 | 92 | 98 | PF00498 | 0.410 |
LIG_FXI_DFP_1 | 139 | 143 | PF00024 | 0.445 |
LIG_GSK3_LRP6_1 | 539 | 545 | PF00069 | 0.423 |
LIG_LIR_Gen_1 | 127 | 134 | PF02991 | 0.359 |
LIG_LIR_Gen_1 | 141 | 150 | PF02991 | 0.407 |
LIG_LIR_Gen_1 | 152 | 161 | PF02991 | 0.389 |
LIG_LIR_Gen_1 | 176 | 183 | PF02991 | 0.371 |
LIG_LIR_Gen_1 | 272 | 279 | PF02991 | 0.383 |
LIG_LIR_Gen_1 | 296 | 304 | PF02991 | 0.292 |
LIG_LIR_Gen_1 | 344 | 353 | PF02991 | 0.320 |
LIG_LIR_Gen_1 | 391 | 400 | PF02991 | 0.413 |
LIG_LIR_Gen_1 | 71 | 80 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 103 | 107 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 141 | 145 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 176 | 180 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 200 | 204 | PF02991 | 0.329 |
LIG_LIR_Nem_3 | 344 | 348 | PF02991 | 0.344 |
LIG_LIR_Nem_3 | 391 | 396 | PF02991 | 0.383 |
LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.367 |
LIG_NRBOX | 326 | 332 | PF00104 | 0.244 |
LIG_PDZ_Class_2 | 643 | 648 | PF00595 | 0.309 |
LIG_SH2_STAT5 | 607 | 610 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 618 | 621 | PF00017 | 0.406 |
LIG_SH3_3 | 214 | 220 | PF00018 | 0.416 |
LIG_SH3_3 | 537 | 543 | PF00018 | 0.427 |
LIG_SH3_3 | 560 | 566 | PF00018 | 0.476 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.457 |
LIG_Sin3_3 | 632 | 639 | PF02671 | 0.299 |
LIG_SUMO_SIM_anti_2 | 350 | 355 | PF11976 | 0.266 |
LIG_SUMO_SIM_anti_2 | 46 | 51 | PF11976 | 0.465 |
LIG_SUMO_SIM_par_1 | 423 | 429 | PF11976 | 0.342 |
LIG_SUMO_SIM_par_1 | 78 | 83 | PF11976 | 0.353 |
LIG_TYR_ITIM | 102 | 107 | PF00017 | 0.458 |
LIG_UBA3_1 | 353 | 360 | PF00899 | 0.265 |
MOD_CDC14_SPxK_1 | 226 | 229 | PF00782 | 0.268 |
MOD_CDK_SPxK_1 | 223 | 229 | PF00069 | 0.266 |
MOD_CK1_1 | 179 | 185 | PF00069 | 0.441 |
MOD_CK1_1 | 254 | 260 | PF00069 | 0.368 |
MOD_CK1_1 | 299 | 305 | PF00069 | 0.478 |
MOD_CK1_1 | 359 | 365 | PF00069 | 0.419 |
MOD_CK1_1 | 370 | 376 | PF00069 | 0.411 |
MOD_CK1_1 | 388 | 394 | PF00069 | 0.349 |
MOD_CK2_1 | 555 | 561 | PF00069 | 0.452 |
MOD_CK2_1 | 579 | 585 | PF00069 | 0.638 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.413 |
MOD_GlcNHglycan | 169 | 172 | PF01048 | 0.617 |
MOD_GlcNHglycan | 241 | 244 | PF01048 | 0.636 |
MOD_GlcNHglycan | 249 | 252 | PF01048 | 0.614 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.756 |
MOD_GlcNHglycan | 264 | 268 | PF01048 | 0.624 |
MOD_GlcNHglycan | 289 | 292 | PF01048 | 0.617 |
MOD_GlcNHglycan | 313 | 316 | PF01048 | 0.638 |
MOD_GlcNHglycan | 337 | 340 | PF01048 | 0.615 |
MOD_GlcNHglycan | 344 | 348 | PF01048 | 0.578 |
MOD_GlcNHglycan | 356 | 359 | PF01048 | 0.552 |
MOD_GlcNHglycan | 361 | 364 | PF01048 | 0.634 |
MOD_GlcNHglycan | 369 | 372 | PF01048 | 0.605 |
MOD_GlcNHglycan | 384 | 388 | PF01048 | 0.598 |
MOD_GlcNHglycan | 393 | 396 | PF01048 | 0.598 |
MOD_GlcNHglycan | 595 | 598 | PF01048 | 0.743 |
MOD_GlcNHglycan | 627 | 630 | PF01048 | 0.446 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.369 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.426 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.422 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.356 |
MOD_GSK3_1 | 247 | 254 | PF00069 | 0.415 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.375 |
MOD_GSK3_1 | 295 | 302 | PF00069 | 0.383 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.553 |
MOD_GSK3_1 | 343 | 350 | PF00069 | 0.408 |
MOD_GSK3_1 | 370 | 377 | PF00069 | 0.432 |
MOD_GSK3_1 | 385 | 392 | PF00069 | 0.319 |
MOD_GSK3_1 | 440 | 447 | PF00069 | 0.564 |
MOD_GSK3_1 | 448 | 455 | PF00069 | 0.574 |
MOD_GSK3_1 | 459 | 466 | PF00069 | 0.499 |
MOD_GSK3_1 | 469 | 476 | PF00069 | 0.575 |
MOD_GSK3_1 | 477 | 484 | PF00069 | 0.535 |
MOD_GSK3_1 | 488 | 495 | PF00069 | 0.479 |
MOD_GSK3_1 | 498 | 505 | PF00069 | 0.498 |
MOD_GSK3_1 | 509 | 516 | PF00069 | 0.469 |
MOD_GSK3_1 | 519 | 526 | PF00069 | 0.476 |
MOD_GSK3_1 | 527 | 534 | PF00069 | 0.485 |
MOD_GSK3_1 | 538 | 545 | PF00069 | 0.530 |
MOD_GSK3_1 | 564 | 571 | PF00069 | 0.625 |
MOD_GSK3_1 | 607 | 614 | PF00069 | 0.524 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.430 |
MOD_N-GLC_1 | 239 | 244 | PF02516 | 0.513 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.610 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.454 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.551 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.366 |
MOD_NEK2_1 | 236 | 241 | PF00069 | 0.430 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.410 |
MOD_NEK2_1 | 306 | 311 | PF00069 | 0.423 |
MOD_NEK2_1 | 332 | 337 | PF00069 | 0.321 |
MOD_NEK2_1 | 354 | 359 | PF00069 | 0.402 |
MOD_NEK2_1 | 361 | 366 | PF00069 | 0.359 |
MOD_NEK2_1 | 385 | 390 | PF00069 | 0.401 |
MOD_NEK2_1 | 398 | 403 | PF00069 | 0.375 |
MOD_NEK2_1 | 80 | 85 | PF00069 | 0.336 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.327 |
MOD_NEK2_2 | 400 | 405 | PF00069 | 0.295 |
MOD_PIKK_1 | 308 | 314 | PF00454 | 0.308 |
MOD_PIKK_1 | 325 | 331 | PF00454 | 0.303 |
MOD_PKA_1 | 132 | 138 | PF00069 | 0.250 |
MOD_PKA_1 | 325 | 331 | PF00069 | 0.252 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.274 |
MOD_PKA_2 | 284 | 290 | PF00069 | 0.494 |
MOD_Plk_1 | 151 | 157 | PF00069 | 0.372 |
MOD_Plk_1 | 175 | 181 | PF00069 | 0.359 |
MOD_Plk_1 | 295 | 301 | PF00069 | 0.400 |
MOD_Plk_1 | 343 | 349 | PF00069 | 0.374 |
MOD_Plk_1 | 611 | 617 | PF00069 | 0.397 |
MOD_Plk_2-3 | 200 | 206 | PF00069 | 0.281 |
MOD_Plk_2-3 | 68 | 74 | PF00069 | 0.435 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.264 |
MOD_Plk_4 | 251 | 257 | PF00069 | 0.277 |
MOD_Plk_4 | 332 | 338 | PF00069 | 0.349 |
MOD_Plk_4 | 347 | 353 | PF00069 | 0.291 |
MOD_ProDKin_1 | 223 | 229 | PF00069 | 0.389 |
MOD_ProDKin_1 | 539 | 545 | PF00069 | 0.464 |
MOD_ProDKin_1 | 568 | 574 | PF00069 | 0.580 |
MOD_SUMO_rev_2 | 415 | 421 | PF00179 | 0.334 |
MOD_SUMO_rev_2 | 605 | 614 | PF00179 | 0.349 |
TRG_DiLeu_BaEn_1 | 612 | 617 | PF01217 | 0.378 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.455 |
TRG_ER_diArg_1 | 284 | 286 | PF00400 | 0.274 |
TRG_ER_diArg_1 | 5 | 7 | PF00400 | 0.639 |
TRG_Pf-PMV_PEXEL_1 | 232 | 237 | PF00026 | 0.464 |
TRG_Pf-PMV_PEXEL_1 | 376 | 381 | PF00026 | 0.493 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I661 | Leptomonas seymouri | 35% | 100% |
A0A0S4IWB9 | Bodo saltans | 29% | 78% |
A0A0S4J206 | Bodo saltans | 32% | 100% |
A0A0S4J954 | Bodo saltans | 21% | 87% |
A0A0S4JTM6 | Bodo saltans | 27% | 88% |
A0A0S4KK37 | Bodo saltans | 30% | 100% |
A0A1X0ND37 | Trypanosomatidae | 26% | 68% |
A0A3Q8I9B4 | Leishmania donovani | 43% | 100% |
A0A3Q8I9D9 | Leishmania donovani | 43% | 100% |
A0A3Q8IC27 | Leishmania donovani | 32% | 100% |
A0A3S5H6L9 | Leishmania donovani | 43% | 100% |
A0A3S5H6M3 | Leishmania donovani | 59% | 94% |
A0A3S5H6M4 | Leishmania donovani | 51% | 99% |
A0A3S7WS66 | Leishmania donovani | 51% | 98% |
A4H6Y8 | Leishmania braziliensis | 50% | 71% |
A4HBX3 | Leishmania braziliensis | 37% | 100% |
A4HZ93 | Leishmania infantum | 32% | 100% |
D1GJ51 | Leishmania infantum | 51% | 100% |
E8NHG9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 85% |
E9AGG2 | Leishmania infantum | 59% | 98% |
E9AGG7 | Leishmania infantum | 54% | 100% |
E9AGG9 | Leishmania infantum | 51% | 100% |
E9ANZ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 53% | 92% |
E9AP04 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 53% | 93% |
E9AP05 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 51% | 100% |
E9AVA1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
Q4QC79 | Leishmania major | 34% | 100% |
Q4QGI0 | Leishmania major | 58% | 100% |
Q4QGI2 | Leishmania major | 55% | 100% |
Q4QGI4 | Leishmania major | 51% | 100% |
Q4QGI6 | Leishmania major | 58% | 100% |
Q4QGI8 | Leishmania major | 53% | 85% |
Q4QGJ0 | Leishmania major | 66% | 100% |
Q4QGJ6 | Leishmania major | 51% | 100% |
Q4QGJ9 | Leishmania major | 67% | 100% |
Q4QGK0 | Leishmania major | 68% | 100% |
Q4QGK1 | Leishmania major | 63% | 92% |
Q4QGK2 | Leishmania major | 53% | 100% |
Q4QGK4 | Leishmania major | 97% | 97% |
Q4QGK8 | Leishmania major | 56% | 100% |
Q4QGL2 | Leishmania major | 56% | 100% |
Q4QGL8 | Leishmania major | 48% | 100% |
Q4QGM1 | Leishmania major | 56% | 84% |
Q9SRL7 | Arabidopsis thaliana | 20% | 69% |
Q9SVN2 | Arabidopsis thaliana | 22% | 81% |